Thomas Hess - 11 Jan 2022 Form 3 Insider Report for Hillstream BioPharma Inc. (THAR)

Role: Chief Financial Officer
Signature: /s/ Randy Milby as Attorney-In-Fact for Thomas Hess
Issuer symbol: THAR
Transactions as of: 11 Jan 2022
Net transactions value: $0
Form type: 3
Filing time: 11 Jan 2022, 20:46:19 UTC
Previous filing: 01 Nov 2021
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney